Price $42.43 |
Market Cap
57.63B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
71.2
|
P/B
3.5
|
P/S
4.75
|
Dividend %
-
|
|
P/CF
336.3
|
P/FCF
44.7
|
Op. Cash Flow
1.87M
|
FCF
0.9
|
|
Op. Margin
9.70%
|
Net Margin
8.00%
|
ROE
6.00%
|
ROI
4.50%
|
|
ROA
3.10%
|
EPS Growth
390.10%
|
Current Ratio
1.5
|
Debt/Equity
53.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostem Technologies Inc (BSEM) | $2.81 | - | - | 31.2M | Strong Buy |
| Capricor Therapeutics Inc (CAPR) | $5.26 | - | - | 109.2M | Strong Buy |
| DocGo Inc (DCGO) | $10.42 | - | - | 764.1M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.19 | - | - | 152.2M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.45 | - | - | 800K | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
